But since it’s split only by staph nucleases, then we can pinpoint where the staph bacteria are active.” The team, which applied in fall 2012 for a final U.S. patent for the probe, plans to refine the probe, so it can be detected deeper in the body and to test its performance with catheter infections, according to McNamara.